Correct Answer: A. Keloid
A keloid is a pathological scar that extends beyond the original wound boundaries due to excessive collagen deposition and abnormal fibroblast proliferation. The discriminating feature here is the one-year timeline post-trauma — keloids typically develop months to years after injury, often 3–12 months or longer, and continue to grow progressively beyond the original wound margins. This distinguishes them from hypertrophic scars, which remain confined within the original wound and regress spontaneously over 12–24 months. Keloids are more common in darker-skinned populations (Indian, African, Asian populations show 15–20× higher incidence), particularly over the chest, shoulders, and upper back — exactly the site mentioned here. The pathophysiology involves dysregulation of TGF-β signaling, increased myofibroblast activity, and impaired apoptosis of fibroblasts, leading to continuous collagen accumulation. Histologically, keloids show thick, haphazardly arranged collagen bundles extending into normal dermis. Management includes intralesional corticosteroids (triamcinolone 40 mg/mL), silicone gel sheets, pressure garments, and surgical excision with adjuvant therapy (radiotherapy or intralesional steroids post-excision to prevent recurrence). The clinical pearl: keloids are a genetic predisposition in Indian populations and require aggressive prevention and early intervention.
Why the other options are wrong
B. Neurofibroma — Neurofibromas are benign nerve sheath tumors that arise from Schwann cells and fibroblasts, NOT from trauma or wound healing. They are typically solitary or multiple (in NF1), present as firm nodules, and have no relationship to previous injury timeline. The history of chest trauma one year ago is the key discriminator — neurofibromas do not develop post-traumatically. Histology shows spindle cells with wavy nuclei, not collagen-dominant architecture. C. Hemangioma — Hemangiomas are benign vascular proliferations composed of endothelial cells, not fibroblasts. While they can be post-traumatic in origin (e.g., port-wine stains), they present as red/purple vascular lesions, not firm fibrotic scars. The clinical presentation and timeline (one year post-trauma with progressive growth beyond wound margins) are inconsistent with hemangioma pathophysiology. Hemangiomas are vascular, not collagen-based. D. Hypertrophic scar — Hypertrophic scars DO occur post-traumatically but remain confined within original wound boundaries and spontaneously regress over 12–24 months. The key discriminator is that this lesion has been present for one year and is described as extending beyond the wound — this is pathognomonic for keloid, not hypertrophic scar. Hypertrophic scars show organized collagen in parallel bundles; keloids show disorganized, excessive collagen extending into normal skin.
High-Yield Facts
- Keloid timeline: develops 3–12 months (or up to years) post-injury and continues growing; hypertrophic scar regresses by 12–24 months.
- Keloid boundary: extends BEYOND original wound margins into normal skin; hypertrophic scar stays WITHIN wound boundaries.
- Keloid epidemiology: 15–20× higher in darker skin (Indian, African, Asian); chest, shoulders, upper back are high-risk sites.
- Keloid pathophysiology: dysregulated TGF-β signaling, impaired fibroblast apoptosis, excessive collagen deposition (types I and III).
- Keloid first-line treatment: intralesional triamcinolone 40 mg/mL monthly; silicone gel sheets; pressure garments for 12+ months.
- Keloid recurrence post-excision: 45–50% without adjuvant therapy; add intralesional steroids or radiotherapy to reduce recurrence.
Mnemonics
KELOID vs HYPERTROPHIC: Beyond vs Within Keloid = Keeps growing Beyond boundaries (months to years, progressive). Hypertrophic = Holds within History (regresses in 12–24 months, confined). SCAR TIMELINE: 3-12-24 Rule Keloid: appears 3–12 months post-injury, grows indefinitely. Hypertrophic: appears early, regresses by 24 months. Use this to date the lesion.
NBE Trap
NBE pairs "post-traumatic scar" with "hypertrophic scar" to trap students who confuse the two; the one-year timeline and progressive growth beyond margins are the discriminators that point to keloid, not hypertrophic scar.
Clinical Pearl
In Indian dermatology and plastic surgery practice, keloids are a major cosmetic and functional problem, especially in darker-skinned patients. Early recognition (growth beyond wound margins within 3–12 months) and aggressive intralesional steroid therapy can prevent the need for surgical excision and reduce the 45–50% recurrence rate post-operatively.
_Reference: Bailey & Love Ch. 6 (Wound Healing & Scars); Robbins Ch. 9 (Inflammation & Repair)_